BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35790599)

  • 21. Long noncoding RNA MALAT1 promotes osterix expression to regulate osteogenic differentiation by targeting miRNA-143 in human bone marrow-derived mesenchymal stem cells.
    Gao Y; Xiao F; Wang C; Wang C; Cui P; Zhang X; Chen X
    J Cell Biochem; 2018 Aug; 119(8):6986-6996. PubMed ID: 29741283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA MALAT1 functions as miR-1 sponge to regulate Connexin 43-mediated ossification of the posterior longitudinal ligament.
    Yuan X; Guo Y; Chen D; Luo Y; Chen D; Miao J; Chen Y
    Bone; 2019 Oct; 127():305-314. PubMed ID: 31280017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
    Zhang C; Xie L; Liang H; Cui Y
    IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA metastasis-associated lung adenocarcinoma transcript-1 promotes osteogenic differentiation of bone marrow stem cells and inhibits osteoclastic differentiation of Mø in osteoporosis via the miR-124-3p/IGF2BP1/Wnt/β-catenin axis.
    Li X
    J Tissue Eng Regen Med; 2022 Mar; 16(3):311-329. PubMed ID: 34962086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALAT1-related signaling pathways in colorectal cancer.
    Xu WW; Jin J; Wu XY; Ren QL; Farzaneh M
    Cancer Cell Int; 2022 Mar; 22(1):126. PubMed ID: 35305641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.
    Zhang L; Lu XQ; Zhou XQ; Liu QB; Chen L; Cai F
    J Cell Physiol; 2019 Apr; 234(4):5097-5105. PubMed ID: 30203547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
    Han W; Liu J
    Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1.
    Liu B; Zhan X; Liu C
    J Oncol; 2021; 2021():8390165. PubMed ID: 34373692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.
    Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Li XL
    J Cancer; 2018; 9(1):71-80. PubMed ID: 29290771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.
    He M; Shen J; Zhang C; Chen Y; Wang W; Tao K
    Med Sci Monit; 2020 Jul; 26():e923123. PubMed ID: 32712618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
    Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.